CONTACT US   SITE MAP   SEARCH


 
 
Investor Relations Home
Investor Events
Webcast ImageWebcast
SuperGen at BMO Capital Markets Focus on Healthcare Conference (Replay)
08/05/08 at 10:15 a.m. ET
Webcast ImageWebcast
Q2 2008 SuperGen Earnings Conference Call (Replay)
08/04/08 at 4:30 p.m. ET
Featured Reports
 
 
Download Documentation Annual Stockholders Meeting
 
Download Documentation 2008 Proxy Statement
Download Documentation 2007 Annual Report
Corporate Profile
SuperGen is a pharmaceutical company whose mission is to prolong, improve the quality of and ultimately, save the lives of those people afflicted with life-threatening diseases, especially cancer.

The company possesses a broad portfolio of proprietary cancer therapies that target a variety of solid tumors, hematological malignancies and blood disorders, offering renewed hope to patients who suffer from these illness... More >>

Stock Quote
SUPG (common stock)
ExchangeNASDAQ GM (US Dollar)
Price$1.82
Change (%) Stock is Down 0.02 (1.09%)
Volume106,839
Data as of 08/20/08 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
Date Title
08/07/08Printer Friendly VersionSuperGen Granted Orphan Drug Designation for MP-470 in Glioblastoma Multiforme
08/04/08Printer Friendly VersionSuperGen Reports 2008 Second Quarter Financial Results
07/29/08Printer Friendly VersionSuperGen To Present at BMO Capital Markets Focus on Healthcare Conference on August 5, 2008
07/28/08Printer Friendly VersionSuperGen to Announce 2008 Second Quarter Financial Results August 4, 2008
Copyright © 2007 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data is provided by Interactive Real Time Services Data and subject to the Term of Use .
Changes in price and volume are subject to market activity.

Privacy Policy
Terms/Conditions
Copyright © Supergen